1. Home
  2. ALZN vs UPC Comparison

ALZN vs UPC Comparison

Compare ALZN & UPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALZN
  • UPC
  • Stock Information
  • Founded
  • ALZN 2016
  • UPC 1998
  • Country
  • ALZN United States
  • UPC China
  • Employees
  • ALZN N/A
  • UPC 225
  • Industry
  • ALZN Medicinal Chemicals and Botanical Products
  • UPC Biotechnology: Pharmaceutical Preparations
  • Sector
  • ALZN Health Care
  • UPC Health Care
  • Exchange
  • ALZN Nasdaq
  • UPC Nasdaq
  • Market Cap
  • ALZN 2.3M
  • UPC 2.0M
  • IPO Year
  • ALZN 2021
  • UPC 2021
  • Fundamental
  • Price
  • ALZN $3.20
  • UPC $3.80
  • Analyst Decision
  • ALZN Strong Buy
  • UPC
  • Analyst Count
  • ALZN 1
  • UPC 0
  • Target Price
  • ALZN $180.00
  • UPC N/A
  • AVG Volume (30 Days)
  • ALZN 429.8K
  • UPC 23.5K
  • Earning Date
  • ALZN 09-10-2025
  • UPC 07-18-2025
  • Dividend Yield
  • ALZN N/A
  • UPC N/A
  • EPS Growth
  • ALZN N/A
  • UPC N/A
  • EPS
  • ALZN N/A
  • UPC N/A
  • Revenue
  • ALZN N/A
  • UPC $19,293,003.00
  • Revenue This Year
  • ALZN $322.64
  • UPC N/A
  • Revenue Next Year
  • ALZN N/A
  • UPC N/A
  • P/E Ratio
  • ALZN N/A
  • UPC N/A
  • Revenue Growth
  • ALZN N/A
  • UPC N/A
  • 52 Week Low
  • ALZN $2.75
  • UPC $2.51
  • 52 Week High
  • ALZN $135.54
  • UPC $2,465.94
  • Technical
  • Relative Strength Index (RSI)
  • ALZN 47.56
  • UPC 45.36
  • Support Level
  • ALZN $2.81
  • UPC $3.54
  • Resistance Level
  • ALZN $3.05
  • UPC $3.80
  • Average True Range (ATR)
  • ALZN 0.17
  • UPC 0.23
  • MACD
  • ALZN 0.09
  • UPC 0.03
  • Stochastic Oscillator
  • ALZN 75.01
  • UPC 68.63

About ALZN Alzamend Neuro Inc.

Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.

About UPC Universe Pharmaceuticals Inc.

Universe Pharmaceuticals Inc is a pharmaceutical company specializing in the manufacturing, marketing, sales and distribution of traditional Chinese medicine derivatives products targeting the elderly with the goal of addressing their physical conditions in the ageing process and promoting their general well-being. The company also sells biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. Its products are under two categories namely treatment and relief for common chronic health conditions in the elderly designed to achieve physical wellness and longevity (Chronic Condition Treatments), and cold and flu medications.

Share on Social Networks: